Private Advisor Group LLC Acquires 5,745 Shares of Halozyme Therapeutics, Inc. (NASDAQ:HALO)
Private Advisor Group LLC boosted its position in Halozyme Therapeutics, Inc. (NASDAQ:HALO – Free Report) by 23.8% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 29,908 shares of the biopharmaceutical company’s stock after purchasing an additional 5,745 shares during the quarter. […]
Private Advisor Group LLC boosted its position in Halozyme Therapeutics, Inc. (NASDAQ:HALO – Free Report) by 23.8% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 29,908 shares of the biopharmaceutical company’s stock after purchasing an additional 5,745 shares during the quarter. […]
